1. Wolf, G. (2000) Cell cycle regulation in diabetic nephropathy Kidney Int., 77(Suppl.), pp. S59 - S66.
2. Wolf, G. and Schroeder, R. and Thaiss, F. and Ziyadeh, F. and Helmchen, U. and Stahl, R. (1998) Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia Kidney Int., 53, pp. 869 - 879.
3. Kuan, C. and al Douahji, M. and Shankland, S. (1998) The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy J. Am. Soc. Nephrol., 9, pp. 986 - 993.
4. al Douahji, M. and Brugarolas, J. and Brown, P. and Stehman-Breen, C. and Alpers, C. and Shankland, S. (1999) The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Kidney Int., 56, pp. 1691 - 1699.
5. Wolf, G. and Schanze, A. and Stahl, R. and Shankland, S. and Amann, K. (2005) p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency Kidney Int., 68, pp. 1583 - 1589.